Latest Heparin Stories
SUNNYVALE, Calif., March 2 /PRNewswire/ -- Cardiva Medical, Inc. announced today that Founder and CEO Augustine Lien has resigned effective March 5. The company's Board of Directors has appointed Rick Anderson, appointed Chairman of the Board in October 2009, to serve as interim CEO. Mr.
SOUTH SAN FRANCISCO, Calif., Feb. 10 /PRNewswire/ -- Portola Pharmaceuticals, Inc.
WALTHAM, Mass., Dec.
NEW YORK, Nov.
SAN FRANCISCO, Nov. 17 /PRNewswire-FirstCall/ -- Merriman Curhan Ford Group, Inc. (Nasdaq: MERR) acted as lead placement agent in PolyMedix Inc.'s (OTC Bulletin Board: PYMX) $20.7 million registered public offering of 20.7 million units.
An outbreak of bloodstream infections appears to have been caused by the contamination of pre-filled heparin and saline syringes made by a single company, according to a report in the October 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Adjustments may be needed to achieve desired anticoagulant effect in some patients New Heparin to Ship Starting October 8 SILVER SPRING, Md., Oct. 1 /PRNewswire-USNewswire/ -- The U.S.
WESTPORT, Conn., Oct. 1 /PRNewswire/ -- Dr. Mark Wurster from The Ohio State University Medical Center presented his findings at the September 29th meeting of the University Health Consortium's Fall Forum. According to Dr.
Heparin, a commonly used anticoagulant, can cause skin lesions, reports a study in CMAJ (Canadian Medical Association Journal).